Norton Hospitals, INC

Norton Hospitals, INC was paid $299.00M by Medicaid between Jan 2018 and Dec 2024, across 826 billing codes. Its largest line is 99284, emergency room visit (serious) — 8.5% of everything it billed.

33Billing provider infoNORTON HOSPITALS, INC
LOUISVILLE, KY 40202

33aNPI1891799227assigned 06/13/2005

33bProvider typeGeneral Acute Care Hospital

28Total paid$299.00M

24GClaims3,175,044

24DCodes billed826

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Kentucky

Rank by total paid#1 of 36

Median peer was paid$36.08M

This provider vs. median8.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official GAST, SHELLEY controls 20+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	4,219	$17K
2019	11,226	$36K
2020	6,192	$75K
2021	38,845	$1.32M
2022	379,721	$25.73M
2023	1,529,843	$144.10M
2024incomplete	1,204,998	$127.72M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	8.5%	82,795	66,586	$25.52M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	8.3%	90,211	78,673	$24.81M
74177	Computed tomography, abdomen and pelvis; with contrast material	3.8%	17,425	14,832	$11.48M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	3.3%	33,977	20,500	$9.78M
J9271	Injection, pembrolizumab, 1 mg	3.2%	1,056	760	$9.54M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.9%	36,822	32,646	$8.77M
C1776	Joint device (implantable)	2.8%	880	640	$8.24M
70450	Computed tomography, head or brain; without contrast material	2.1%	19,606	15,226	$6.40M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	2.1%	11,025	9,653	$6.20M
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	2.0%	3,888	2,627	$5.94M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	1.9%	49,359	44,591	$5.81M
J3490	Unclassified drugs	1.8%	99,742	25,842	$5.44M

814 more codes

70551	Magnetic resonance imaging, brain; without contrast material	1.4%	6,386	$4.06M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.3%	6,136	$3.88M
72148	Magnetic resonance imaging, lumbar spine; without contrast material	1.1%	4,988	$3.41M
J0585	Injection, onabotulinumtoxina, 1 unit	1.1%	5,575	$3.37M
96375	Therapeutic injection; each additional sequential IV push	1.1%	28,995	$3.21M
74176	Computed tomography, abdomen and pelvis; without contrast material	1.0%	6,802	$3.12M
71275	Computed tomographic angiography, chest, with contrast material	1.0%	6,203	$3.12M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	54,864	$2.48M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	29,410	$2.40M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	46,072	$2.34M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	7,051	$2.17M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	5,208	$2.10M
77386		<1%	4,590	$2.05M
72141		<1%	2,815	$1.98M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	4,929	$1.95M
72125	Computed tomography, cervical spine; without contrast material	<1%	4,770	$1.95M
96361	Intravenous infusion, hydration; each additional hour	<1%	31,007	$1.85M
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	8,231	$1.76M
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	4,972	$1.73M
80053	Comprehensive metabolic panel	<1%	139,764	$1.72M
76770		<1%	7,651	$1.71M
71045	Radiologic examination, chest; single view	<1%	31,660	$1.61M
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	34,342	$1.60M
G0378	Hospital observation service, per hour	<1%	16,992	$1.53M
78815	Positron emission tomography (PET) for limited area imaging	<1%	1,193	$1.53M
71046	Radiologic examination, chest; 2 views	<1%	17,876	$1.49M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	10,214	$1.49M
58571		<1%	757	$1.46M
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	7,734	$1.31M
74019		<1%	9,383	$1.28M
93458		<1%	701	$1.27M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	25,811	$1.23M
72131		<1%	2,817	$1.17M
71250		<1%	4,766	$1.16M
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	2,201	$1.15M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	1,299	$1.15M
93017		<1%	3,307	$1.13M
36415	Collection of venous blood by venipuncture	<1%	198,260	$1.11M
47562		<1%	853	$1.10M
70496		<1%	1,962	$1.10M
93320		<1%	3,372	$1.09M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	2,286	$1.06M
58661		<1%	700	$1.04M
G0330	Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room	<1%	1,049	$1.03M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,422	$985K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	11,663	$975K
Q5121	Injection, infliximab-axxq, biosimilar, (avsola), 10 mg	<1%	516	$967K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	143,952	$960K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	7,439	$954K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	28,959	$944K
70498		<1%	1,918	$916K
76830	Ultrasound, transvaginal	<1%	4,894	$897K
44970		<1%	526	$897K
J2350	Injection, ocrelizumab, 1 mg	<1%	53	$895K
74018		<1%	7,599	$876K
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	<1%	147	$874K
62323		<1%	3,169	$864K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	3,496	$858K
C1762	Connective tissue, human (includes fascia lata)	<1%	287	$834K
95713		<1%	2,702	$834K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	10,533	$811K
72146		<1%	1,153	$770K
93975		<1%	3,429	$755K
70486		<1%	1,844	$753K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,450	$733K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	1,356	$723K
64615		<1%	5,208	$723K
70491		<1%	1,912	$694K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	106	$684K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,723	$678K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	1,893	$659K
83880		<1%	19,748	$650K
64643		<1%	747	$638K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	8,928	$635K
C1769	Guide wire	<1%	4,013	$634K
74178		<1%	1,153	$624K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	2,365	$615K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	4,097	$599K
93971		<1%	3,534	$590K
76536		<1%	3,788	$587K
77063	Screening digital breast tomosynthesis, bilateral	<1%	10,270	$584K
C1889	Implantable/insertable device, not otherwise classified	<1%	301	$574K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	20,494	$568K
27447		<1%	699	$563K
73221		<1%	1,122	$562K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	152	$561K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	12,059	$554K
J0185	Injection, aprepitant, 1 mg	<1%	1,811	$553K
72156		<1%	803	$543K
74183		<1%	1,005	$543K
72197		<1%	877	$540K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	11,739	$538K
C1874	Stent, coated/covered, with delivery system	<1%	198	$535K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	3,271	$535K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	11,580	$534K
36512		<1%	1,081	$534K
76801		<1%	3,936	$523K
73630		<1%	5,677	$514K
84484		<1%	31,915	$492K
95812		<1%	1,619	$489K
41899	Unlisted procedure, dentoalveolar structures	<1%	672	$487K
J9173	Injection, durvalumab, 10 mg	<1%	137	$476K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	958	$468K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	23,751	$465K
96415		<1%	2,607	$462K
J1756	Injection, iron sucrose, 1 mg	<1%	6,004	$453K
72158		<1%	752	$450K
93970		<1%	1,965	$431K
77334		<1%	866	$428K
54161		<1%	1,028	$423K
76642		<1%	4,445	$422K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,773	$418K
93325		<1%	4,434	$413K
C1781	Mesh (implantable)	<1%	538	$398K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	2,171	$384K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	12,674	$380K
95716		<1%	856	$370K
76870		<1%	1,943	$369K
72157		<1%	551	$369K
64642		<1%	698	$358K
73130		<1%	5,094	$355K
73610		<1%	4,677	$351K
59025	Fetal non-stress test	<1%	5,263	$347K
73562		<1%	4,696	$347K
43235		<1%	686	$345K
54300		<1%	561	$342K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	12,501	$337K
96367		<1%	3,216	$337K
77066	Tomosynthesis, mammo	<1%	2,606	$330K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	4,117	$328K
62321		<1%	908	$325K
73030		<1%	4,240	$323K
64721		<1%	732	$322K
36561		<1%	776	$322K
J0897	Injection, denosumab, 1 mg	<1%	240	$321K
36430		<1%	1,765	$317K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	126	$316K
80048	Basic metabolic panel (calcium, ionized)	<1%	23,118	$316K
72128		<1%	962	$315K
74455		<1%	1,445	$314K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	2,265	$301K
95700		<1%	2,377	$299K
77412		<1%	1,393	$299K
77295		<1%	418	$294K
70544		<1%	862	$293K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	1,071	$293K
C8908	Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral	<1%	520	$293K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	10,020	$292K
58558		<1%	451	$291K
96376		<1%	3,439	$288K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	1,229	$284K
88342		<1%	4,395	$284K
J2997	Injection, alteplase recombinant, 1 mg	<1%	2,576	$272K
96417		<1%	1,880	$270K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	4,817	$269K
88341		<1%	1,699	$268K
78431		<1%	215	$259K
20680		<1%	293	$257K
93225		<1%	1,560	$255K
83735		<1%	30,991	$255K
74174		<1%	448	$253K
51600		<1%	1,402	$251K
95782		<1%	393	$250K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	187	$249K
52332		<1%	604	$247K
77300		<1%	837	$246K
73590		<1%	3,333	$246K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	1,922	$245K
78264		<1%	856	$244K
49083		<1%	768	$239K
73090		<1%	3,342	$238K
50590		<1%	139	$236K
87486		<1%	8,580	$232K
75574		<1%	506	$230K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	4,096	$229K
97161		<1%	5,232	$223K
87581		<1%	8,448	$220K
77336		<1%	2,510	$217K
19083		<1%	522	$215K
49650		<1%	63	$213K
64644		<1%	460	$212K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	7,822	$211K
95811		<1%	454	$211K
51728		<1%	873	$210K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	7,718	$207K
93351		<1%	495	$204K
73110		<1%	2,871	$203K
95886		<1%	1,080	$203K
72100		<1%	2,202	$198K
J2785	Injection, regadenoson, 0.1 mg	<1%	1,524	$194K
78227		<1%	575	$193K
95813		<1%	589	$188K
C1768	Graft, vascular	<1%	79	$186K
84443	Thyroid stimulating hormone (TSH)	<1%	10,248	$182K
83690		<1%	27,331	$181K
74230		<1%	1,131	$181K
73700		<1%	617	$179K
77062		<1%	2,769	$179K
72040		<1%	1,902	$177K
27130		<1%	154	$175K
88307		<1%	1,409	$175K
93798		<1%	5,117	$171K
73560		<1%	2,125	$169K
51784		<1%	902	$166K
J2704	Injection, propofol, 10 mg	<1%	57,622	$164K
72110		<1%	1,548	$163K
36593		<1%	964	$161K
10060		<1%	871	$161K
76882		<1%	1,291	$161K
12011		<1%	1,427	$159K
84703		<1%	26,156	$157K
86850		<1%	15,328	$156K
76819	Fetal biophysical profile; without non-stress testing	<1%	1,115	$156K
77065	Tomosynthesis, mammo	<1%	2,191	$155K
70487		<1%	353	$154K
73070		<1%	2,361	$154K
C1726	Catheter, balloon dilatation, non-vascular	<1%	502	$153K
80061	Lipid panel	<1%	9,874	$153K
J9299	Injection, nivolumab, 1 mg	<1%	28	$153K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	<1%	353	$153K
74240		<1%	993	$153K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	1,759	$150K
96411		<1%	1,128	$147K
54640		<1%	196	$144K
49591		<1%	123	$143K
94660		<1%	968	$143K
81025		<1%	20,151	$142K
77290		<1%	940	$140K
88185		<1%	514	$139K
97535	Self-care/home management training, each 15 minutes	<1%	5,690	$138K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	5,675	$136K
12001		<1%	1,200	$135K
77080		<1%	2,136	$134K
55175		<1%	463	$133K
73521		<1%	1,218	$132K
73502		<1%	1,854	$132K
76885		<1%	967	$131K
93308		<1%	830	$130K
99213	Doctor's office visit, returning patient (routine)	<1%	5,378	$127K
82728		<1%	10,579	$127K
97162		<1%	3,045	$125K
93880		<1%	876	$123K
72132		<1%	428	$122K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	741	$122K
92526		<1%	1,801	$122K
93922		<1%	964	$122K
54360		<1%	375	$121K
73552		<1%	1,501	$121K
86920		<1%	1,498	$120K
94060		<1%	1,009	$120K
88360		<1%	682	$120K
J9171	Injection, docetaxel, 1 mg	<1%	92	$116K
72082		<1%	832	$115K
71271		<1%	2,705	$114K
88304		<1%	2,468	$114K
78306		<1%	748	$113K
97116		<1%	3,722	$111K
85730		<1%	17,537	$110K
99157		<1%	1,469	$109K
92611		<1%	869	$108K
95910		<1%	611	$107K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	24	$104K
85027		<1%	19,598	$103K
86900		<1%	17,360	$101K
77072		<1%	1,034	$101K
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	<1%	2,378	$101K
51797		<1%	678	$101K
76825		<1%	460	$101K
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	<1%	617	$100K
87086	Culture, bacterial; quantitative colony count, urine	<1%	14,634	$99K
83605		<1%	6,292	$99K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	616	$99K
77061		<1%	1,931	$98K
73060		<1%	1,517	$96K
77387		<1%	761	$96K
77002		<1%	521	$96K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	2,195	$94K
94726		<1%	913	$93K
14040		<1%	302	$93K
G0382	Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	474	$93K
36902		<1%	179	$92K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	5,120	$92K
96416		<1%	424	$92K
85610		<1%	21,010	$91K
96409		<1%	773	$90K
81001		<1%	35,945	$90K
82803		<1%	3,189	$89K
C1760	Closure device, vascular (implantable/insertable)	<1%	223	$87K
95874		<1%	578	$85K
73200		<1%	252	$84K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	2,285	$84K
95911		<1%	351	$82K
29580		<1%	1,920	$81K
77075		<1%	261	$81K
J2323	Injection, natalizumab, 1 mg	<1%	14	$80K
95819		<1%	372	$80K
10005		<1%	191	$80K
42830		<1%	169	$79K
70543		<1%	107	$79K
95816		<1%	389	$79K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	3,358	$79K
64483		<1%	168	$79K
84439		<1%	5,932	$78K
96401		<1%	1,518	$78K
84702		<1%	6,045	$77K
Q9969	Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose	<1%	3,521	$76K
92610		<1%	644	$76K
77001		<1%	499	$75K
94010		<1%	1,130	$75K
91200		<1%	618	$74K
72072		<1%	854	$74K
C1788	Port, indwelling (implantable)	<1%	198	$73K
87040		<1%	7,148	$73K
83036	Hemoglobin; glycosylated (A1C)	<1%	6,752	$73K
96402		<1%	872	$72K
73140		<1%	1,201	$72K
67311		<1%	90	$72K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	9,938	$71K
54163		<1%	119	$70K
82565		<1%	5,030	$70K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	8,532	$70K
A4648	Tissue marker, implantable, any type, each	<1%	766	$67K
77301		<1%	35	$67K
80069		<1%	6,950	$64K
J3370	Injection, vancomycin hcl, 500 mg	<1%	4,618	$64K
95806		<1%	549	$63K
64493		<1%	133	$63K
51741		<1%	485	$63K
84112		<1%	900	$62K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	379	$62K
82607		<1%	3,646	$61K
93226		<1%	1,285	$61K
72050		<1%	628	$61K
12002		<1%	565	$60K
86481		<1%	788	$59K
73718		<1%	119	$59K
90677		<1%	198	$58K
86140		<1%	12,730	$58K
84100		<1%	10,220	$57K
84145		<1%	2,715	$56K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	2,555	$56K
86901		<1%	15,849	$56K
J0690	Injection, cefazolin sodium, 500 mg	<1%	18,807	$56K
76937		<1%	584	$56K
95885		<1%	503	$54K
10061		<1%	240	$54K
72070		<1%	611	$54K
85007		<1%	16,128	$53K
83540		<1%	7,732	$53K
90715		<1%	1,882	$53K
94760		<1%	2,062	$53K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	36,240	$52K
29125		<1%	579	$52K
80074		<1%	1,131	$51K
86902		<1%	1,394	$51K
70480		<1%	134	$51K
70360		<1%	821	$50K
54304		<1%	68	$50K
76000		<1%	437	$50K
97166		<1%	776	$50K
76800		<1%	282	$50K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	44,638	$49K
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	22	$49K
J3489	Injection, zoledronic acid, 1 mg	<1%	585	$49K
94644		<1%	1,563	$49K
86003		<1%	627	$48K
43762		<1%	188	$48K
97165		<1%	776	$48K
72170		<1%	973	$48K
99153	Mod sedat endo service >5yrs	<1%	600	$47K
81003		<1%	25,319	$46K
87536		<1%	741	$46K
82330		<1%	2,286	$45K
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	4,219	$45K
77280		<1%	691	$45K
64645		<1%	60	$44K
71101		<1%	720	$44K
70250		<1%	379	$44K
31575		<1%	394	$44K
94729		<1%	721	$44K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	86	$42K
C1729	Catheter, drainage	<1%	830	$42K
73080		<1%	701	$41K
88313		<1%	545	$41K
72195		<1%	72	$41K
73000		<1%	618	$40K
29581		<1%	781	$39K
86922		<1%	625	$39K
86870		<1%	557	$39K
75565		<1%	94	$39K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	20,214	$38K
95909		<1%	333	$38K
93321		<1%	336	$38K
31624		<1%	54	$38K
25605		<1%	114	$37K
36600		<1%	1,386	$37K
82550		<1%	3,814	$37K
J3480	Injection, potassium chloride, per 2 meq	<1%	3,101	$37K
49500		<1%	12	$37K
82784		<1%	2,605	$36K
87070		<1%	4,140	$36K
29881		<1%	57	$36K
76857		<1%	420	$36K
76942		<1%	221	$35K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	6,591	$35K
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	<1%	2,033	$35K
83970		<1%	995	$35K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	51,227	$35K
83516		<1%	1,189	$35K
86945		<1%	751	$35K
99155		<1%	993	$34K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	55	$33K
86923		<1%	1,063	$33K
82150		<1%	2,770	$33K
78708		<1%	111	$32K
87077		<1%	4,699	$32K
85379		<1%	4,298	$32K
38222		<1%	205	$32K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	189	$31K
86360		<1%	815	$31K
72081		<1%	209	$30K
29105		<1%	262	$30K
77373		<1%	40	$30K
64616		<1%	117	$30K
94762		<1%	444	$30K
72126		<1%	126	$29K
97750		<1%	992	$29K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	41,260	$29K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	353	$28K
95912		<1%	104	$28K
97168		<1%	607	$28K
99152		<1%	545	$28K
87186		<1%	3,930	$28K
82746		<1%	1,868	$27K
83021		<1%	1,792	$27K
72020		<1%	244	$27K
97164		<1%	657	$26K
J1170	Injection, hydromorphone, up to 4 mg	<1%	15,652	$26K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	2,451	$26K
70470		<1%	87	$26K
20930		<1%	44	$25K
76604		<1%	234	$25K
99214	Doctor's office visit, returning patient (more involved)	<1%	991	$25K
64494		<1%	76	$25K
26055		<1%	58	$25K
96368		<1%	937	$25K
76827		<1%	436	$25K
87522	Neg quan hep c or qual rna	<1%	708	$24K
72083		<1%	184	$24K
86664		<1%	1,251	$23K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	6,481	$23K
90651		<1%	126	$23K
85652		<1%	8,831	$23K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	3,087	$23K
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	2,883	$22K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	30,793	$22K
J9045	Injection, carboplatin, 50 mg	<1%	811	$22K
62328		<1%	52	$22K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	1,698	$22K
73620		<1%	366	$22K
11043		<1%	86	$22K
84132		<1%	3,584	$22K
83615		<1%	2,907	$21K
86780		<1%	2,128	$21K
87205		<1%	6,008	$21K
94664		<1%	3,740	$21K
J1750	Injection, iron dextran, 50 mg	<1%	132	$21K
87529		<1%	525	$20K
92523		<1%	209	$20K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	3,496	$20K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	4,696	$20K
36591		<1%	987	$20K
74170		<1%	31	$20K
43245		<1%	75	$20K
93976		<1%	161	$19K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	3,074	$19K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	177	$19K
62304		<1%	31	$18K
74328		<1%	161	$18K
C9113	Injection, pantoprazole sodium, per vial	<1%	4,412	$18K
J9070	Cyclophosphamide, 100 mg	<1%	35	$18K
85045		<1%	4,889	$17K
72202		<1%	240	$17K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	2,828	$17K
88377		<1%	116	$17K
95873		<1%	141	$17K
82947		<1%	2,990	$17K
64718		<1%	28	$16K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	278	$16K
C1763	Connective tissue, non-human (includes synthetic)	<1%	27	$16K
84156		<1%	2,615	$16K
82810		<1%	185	$16K
82378		<1%	741	$16K
73720		<1%	18	$16K
96450		<1%	80	$16K
88302		<1%	511	$15K
A9562	Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries	<1%	180	$15K
P9041	Infusion, albumin (human), 5%, 50 ml	<1%	241	$15K
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	<1%	674	$15K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	5,057	$15K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	3,084	$15K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	415	$15K
J9190	Injection, fluorouracil, 500 mg	<1%	1,302	$15K
80197		<1%	950	$15K
64635		<1%	20	$15K
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	<1%	369	$15K
86038		<1%	995	$15K
86665		<1%	1,115	$14K
88184		<1%	652	$14K
74181		<1%	27	$14K
93923		<1%	108	$14K
87902		<1%	69	$14K
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	8,705	$14K
88312		<1%	296	$14K
82785		<1%	609	$14K
94645		<1%	370	$14K
73660		<1%	249	$13K
77338		<1%	35	$13K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	835	$13K
87340		<1%	1,728	$13K
43275		<1%	14	$13K
82140		<1%	735	$13K
C2628	Catheter, occlusion	<1%	117	$13K
82570		<1%	2,538	$12K
86803		<1%	1,151	$12K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	7,554	$12K
70260		<1%	83	$12K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	580	$12K
94621		<1%	33	$12K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	3,626	$12K
86147		<1%	293	$12K
C1758	Catheter, ureteral	<1%	444	$12K
J9267	Injection, paclitaxel, 1 mg	<1%	307	$12K
J1453	Injection, fosaprepitant, 1 mg	<1%	66	$11K
93312		<1%	66	$11K
84460		<1%	2,159	$11K
94618		<1%	342	$11K
99156		<1%	511	$11K
87075		<1%	1,199	$11K
J1644	Injection, heparin sodium, per 1000 units	<1%	4,197	$11K
20610		<1%	52	$11K
83655		<1%	865	$11K
86706		<1%	1,223	$11K
88112		<1%	256	$10K
86663		<1%	1,110	$10K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	1,637	$10K
84403		<1%	432	$10K
90686		<1%	776	$10K
77076		<1%	81	$10K
43249		<1%	13	$10K
86160		<1%	623	$10K
86704		<1%	880	$10K
87046		<1%	838	$10K
86304		<1%	508	$10K
64484		<1%	29	$10K
85240		<1%	567	$10K
80076		<1%	694	$10K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	8,964	$9K
23350		<1%	40	$9K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	256	$9K
27096		<1%	15	$9K
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	1,137	$9K
74270		<1%	41	$9K
97167		<1%	125	$9K
J1610	Injection, glucagon hydrochloride, per 1 mg	<1%	64	$9K
88173		<1%	151	$9K
82010		<1%	1,162	$9K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	1,870	$9K
G0381	Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	72	$8K
75573		<1%	15	$8K
29826		<1%	17	$8K
82533		<1%	471	$8K
24640		<1%	64	$8K
36416		<1%	1,613	$8K
36590		<1%	21	$8K
83550		<1%	1,069	$8K
76506		<1%	48	$8K
85576		<1%	265	$8K
91320		<1%	95	$8K
87210		<1%	3,850	$8K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	361	$8K
76820		<1%	47	$8K
84450		<1%	1,706	$8K
72192		<1%	29	$7K
84295		<1%	1,313	$7K
85384		<1%	971	$7K
Q0222	Injection, bebtelovimab, 175 mg	<1%	21	$7K
84550		<1%	1,425	$7K
87088		<1%	1,177	$7K
82247		<1%	1,032	$7K
87799		<1%	337	$7K
86146		<1%	263	$7K
83520		<1%	335	$7K
A9585	Injection, gadobutrol, 0.1 ml	<1%	208	$7K
J1953	Injection, levetiracetam, 10 mg	<1%	1,463	$7K
72220		<1%	106	$7K
86301		<1%	443	$7K
10120		<1%	33	$7K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	1,022	$7K
75625		<1%	22	$7K
85347		<1%	600	$7K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	645	$6K
96523		<1%	333	$6K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	222	$6K
22853		<1%	14	$6K
86334		<1%	397	$6K
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	407	$6K
73222		<1%	16	$6K
87045		<1%	792	$6K
72052		<1%	47	$6K
80164		<1%	431	$6K
83521		<1%	321	$6K
85014		<1%	2,220	$6K
87427		<1%	699	$6K
19081		<1%	35	$6K
84165		<1%	702	$6K
90688		<1%	577	$6K
80143		<1%	364	$6K
82248		<1%	1,191	$6K
J3411	Injection, thiamine hcl, 100 mg	<1%	1,437	$5K
86800		<1%	450	$5K
83010		<1%	387	$5K
82435		<1%	855	$5K
59820		<1%	12	$5K
86308		<1%	1,355	$5K
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	973	$5K
J9370	Vincristine sulfate, 1 mg	<1%	769	$5K
82945		<1%	686	$5K
29827		<1%	17	$5K
85660		<1%	886	$5K
82977		<1%	705	$5K
85018		<1%	2,424	$5K
86235		<1%	88	$5K
P9073	Platelets, pheresis, pathogen-reduced, each unit	<1%	23	$5K
82270		<1%	1,445	$5K
84153		<1%	195	$5K
80179		<1%	360	$5K
73100		<1%	97	$5K
83921		<1%	293	$5K
99195		<1%	149	$5K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,110	$5K
88182		<1%	125	$5K
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	195	$4K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	840	$4K
83930		<1%	715	$4K
89051		<1%	1,070	$4K
84146		<1%	253	$4K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	131	$4K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	421	$4K
12013		<1%	45	$4K
J0694	Injection, cefoxitin sodium, 1 gm	<1%	421	$4K
86703		<1%	423	$4K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	7,174	$4K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	74	$4K
94667		<1%	155	$4K
J0248	Injection, remdesivir, 1 mg	<1%	51	$4K
74220		<1%	30	$4K
84157		<1%	725	$4K
80202		<1%	281	$4K
85597		<1%	488	$4K
J1940	Injection, furosemide, up to 20 mg	<1%	1,917	$4K
85245		<1%	193	$4K
J0456	Injection, azithromycin, 500 mg	<1%	974	$3K
88300		<1%	217	$3K
J3360	Injection, diazepam, up to 5 mg	<1%	330	$3K
82310		<1%	390	$3K
84481		<1%	182	$3K
88311		<1%	208	$3K
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	2,654	$3K
G0008	Administration of influenza virus vaccine	<1%	187	$3K
Q3014	Telehealth originating site facility fee	<1%	182	$3K
90739		<1%	32	$3K
87497		<1%	118	$3K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	2,757	$3K
87102		<1%	424	$3K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	81	$3K
87901		<1%	15	$3K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	269	$3K
84305		<1%	171	$3K
95711		<1%	76	$3K
86200		<1%	243	$3K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	26	$3K
J2560	Injection, phenobarbital sodium, up to 120 mg	<1%	49	$3K
69200		<1%	40	$3K
86592		<1%	510	$3K
90461		<1%	213	$3K
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	136	$3K
86225		<1%	315	$3K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,042	$3K
J2060	Injection, lorazepam, 2 mg	<1%	2,613	$3K
88331		<1%	49	$2K
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,717	$2K
86762		<1%	254	$2K
85397		<1%	111	$2K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	2,058	$2K
77399		<1%	36	$2K
83001		<1%	141	$2K
87899		<1%	189	$2K
81002		<1%	247	$2K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	32	$2K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	3,260	$2K
87015		<1%	427	$2K
87116		<1%	306	$2K
87177		<1%	270	$2K
J2805	Injection, sincalide, 5 micrograms	<1%	77	$2K
85244		<1%	126	$2K
80177		<1%	201	$2K
69209		<1%	14	$2K
82525		<1%	134	$2K
86431		<1%	442	$2K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	27	$2K
86708		<1%	238	$2K
85613		<1%	299	$2K
76828		<1%	16	$2K
J1171	Injection, hydromorphone, 0.1 mg	<1%	1,267	$2K
29505		<1%	12	$2K
J1956	Injection, levofloxacin, 250 mg	<1%	395	$2K
86341		<1%	45	$2K
30300		<1%	27	$2K
76826		<1%	16	$2K
86757		<1%	63	$2K
84480		<1%	129	$2K
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	149	$2K
87900		<1%	15	$2K
85246		<1%	101	$2K
J1790	Injection, droperidol, up to 5 mg	<1%	976	$2K
86618		<1%	100	$2K
87081		<1%	274	$2K
82043		<1%	333	$2K
86376		<1%	85	$2K
87449		<1%	204	$2K
83002		<1%	83	$1K
84270		<1%	79	$1K
81243		<1%	48	$1K
82397		<1%	89	$1K
88108		<1%	69	$1K
99215	Doctor's office visit, returning patient (complex)	<1%	51	$1K
0279U		<1%	97	$1K
82657		<1%	43	$1K
86593		<1%	246	$1K
84134		<1%	147	$1K
84432		<1%	111	$1K
94625		<1%	139	$1K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	178	$1K
J2470	Injection, pantoprazole sodium, 40 mg	<1%	529	$1K
86617		<1%	65	$1K
84436		<1%	195	$1K
86812		<1%	42	$1K
J2598	Injection, vasopressin, 1 unit	<1%	21	$1K
86039		<1%	131	$1K
94668		<1%	19	$988.20
87498		<1%	40	$947.43
87206		<1%	300	$944.44
J0290	Injection, ampicillin sodium, 500 mg	<1%	201	$908.13
82668		<1%	61	$897.72
82805		<1%	13	$894.05
A9270	Non-covered item or service	<1%	7,805	$878.25
84681		<1%	78	$876.10
83525		<1%	84	$833.03
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	44	$798.08
86705		<1%	83	$781.03
84300		<1%	230	$757.02
86880		<1%	79	$748.38
82670		<1%	27	$748.08
87496		<1%	27	$701.80
83986		<1%	196	$689.00
90472	Immunization administration, each additional vaccine (list separately)	<1%	90	$686.90
83498		<1%	30	$671.38
87532		<1%	26	$666.71
86644		<1%	31	$660.45
82180		<1%	74	$628.30
82985		<1%	60	$621.38
85303		<1%	88	$595.15
83876		<1%	16	$559.46
82627		<1%	26	$545.52
J3372	Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg	<1%	87	$539.58
82365		<1%	52	$519.13
J7120	Ringers lactate infusion, up to 1000 cc	<1%	153	$480.04
84402		<1%	28	$479.07
90656		<1%	36	$462.73
0124A		<1%	20	$440.14
82652		<1%	12	$439.70
93271		<1%	18	$435.40
J2800	Injection, methocarbamol, up to 10 ml	<1%	95	$424.33
88333		<1%	14	$419.86
85300		<1%	55	$417.95
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	<1%	35	$410.89
J9260	Injection, methotrexate sodium, 50 mg	<1%	226	$403.99
82379		<1%	29	$392.91
82164		<1%	13	$378.67
84630		<1%	57	$368.35
90662		<1%	106	$357.44
84238		<1%	12	$329.13
86355		<1%	19	$301.84
86359		<1%	21	$301.84
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	28	$297.41
86645		<1%	13	$294.70
84207		<1%	15	$282.41
85306		<1%	29	$235.00
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	16	$228.23
84075		<1%	13	$209.88
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	278	$194.41
82105		<1%	13	$184.47
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	99	$173.00
83993		<1%	12	$162.64
86682		<1%	13	$158.33
87106		<1%	14	$113.52
J1630	Injection, haloperidol, up to 5 mg	<1%	158	$108.34
86008		<1%	13	$107.58
84133		<1%	30	$96.68
C8937	Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)	<1%	321	$32.04
A0425	Ground mileage, per statute mile	<1%	42	$1.74
91312		<1%	20	$0.12
T2005	Non-emergency transportation; stretcher van	0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGAST, SHELLEY (VP MANAGED CARE)

Parent organizationNORTON HOSPITALS INC

Same official

Other billing entities under GAST, SHELLEY

Full network →

Provider	Location	Paid
Norton Hospitals INC	Louisville, KY	$419.58M
Community Medical Associates, INC.	Louisville, KY	$135.33M
Norton Childrens Medical Group, LLC	Louisville, KY	$107.36M
Community Medical Associates, INC.	Louisville, KY	$48.97M
Norton Clark Hospital, LLC	Jeffersonville, IN	$19.62M
Norton - Kings Daughters Health INC	Madison, IN	$11.81M
Norton Scott Hospital, LLC	Scottsburg, IN	$9.17M
Norton Clark Physician Practices, LLC	Clarksville, IN	$7.07M
Norton Hospitals INC	Louisville, KY	$3.38M
Community Medical Associates, INC.	Louisville, KY	$1.21M
Norton Children's Medical Group, LLC	Louisville, KY	$1.15M
Community Medical Associates, INC.	Louisville, KY	$957K
Community Medical Associates, INC.	Louisville, KY	$808K
Norton Scott Hospital, LLC	Scottsburg, IN	$560K
Norton Hospitals, INC	Louisville, KY	$438K
Community Medical Associates, INC.	Louisville, KY	$357K
Norton Clark Physician Practices, LLC	Sellersburg, IN	$273K
Norton Children's Medical Group, LLC	Louisville, KY	$260K
Norton Children's Medical Group, LLC	Louisville, KY	$238K
Norton Children's Medical Group, LLC	Louisville, KY	$189K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.